PFIZER INC (PFE)
US7170811035 - Common Stock
PFIZER INC
NYSE:PFE (10/21/2024, 2:44:09 PM)
28.945
-0.27 (-0.94%)
Company Profile
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The company is headquartered in New York City, New York and currently employs 88,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.
Company Info
PFIZER INC
66 Hudson Boulevard East
New York City NEW YORK 10017
P: 12127332323
CEO: Albert Bourla
Employees: 88000
Website: https://www.pfizer.com/
PFE News
9 hours ago - The Motley Fool1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to AvoidIncome investors have both good and not-so-good options in the healthcare sector.
2 days ago - The Motley Fool3 Bargain Stocks to Buy in a Market That's Priced for PerfectionYes, bargains can still be found in the stock market.
3 days ago - The Business JournalsPfizer lays off 80 employees in McPherson as part of larger cost-cutting program3 days ago - The Motley Fool3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right NowThese stocks could deliver big over the long term.
4 days ago - Yahoo FinanceConsumer groups ask FTC to block Novo Holdings-Catalent dealFive U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Nordisk's controlling shareholder from acquiring contract drug manufacturer Catalent, saying the deal threatens competition in weight loss drugs and cutting-edge gene therapies. U.S. Public Interest Research Group, Service Employees International Union (SEIU) and others expressed concerns in a letter to the FTC about the $16.5 billion deal, which Novo Holdings has said would boost supply of Wegovy, Novo's blockbuster GLP-1 injectable weight loss drug. Last week, U.S. Senator Elizabeth Warren, a Democrat, called on the FTC to look closely at the deal over similar concerns.
5 days ago - The Motley FoolWhy I'm Considering Leaning Heavily Into PfizerPfizer's high dividend yield and robust pipeline could offer significant returns for patient investors.
PFE Twits
Here you can normally see the latest stock twits on PFE, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
